# Evren Ucok

> Evren Ucok is a Series A investor at Earlybird Venture Capital backing Medical and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Earlybird Venture Capital](https://shizune.co/investors/profile/earlybird-venture-capital)
- Location: Istanbul, Turkey
- Total investments: 3
- Last investment: Nov 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/evren-ucok/1/23b/339

Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |
| Life Science | 1 | 33% |
| Biotechnology | 1 | 33% |
| Crowdsourcing | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Seed | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Turkey | 1 | 33% |
| Belgium | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Amyl Therapeutics | Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. | $5.7M | Series A | Nov 07, 2023 |  |
| idemama | Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey. |  | Series A | Nov 01, 2012 |  |
| idemama | Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey. |  | Seed |  |  |

3 of 3 investments shown.

## Co-investors
- [Meusinvest (Noshaq)](https://shizune.co/investors/profile/meusinvest) — VC Fund, 2 deals together
- [Mérieux Equity Partners](https://shizune.co/investors/profile/merieux-equity-partners) — VC Fund, 1 deal together
- [Mérieux Equity Partners](https://shizune.co/investors/profile/m%C3%A9rieux-equity-partners) — VC Fund, 1 deal together

## About Earlybird Venture Capital

VC Fund · Berlin, Germany

Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.

5 contacts available at Earlybird Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Andre Retterath | Principal | https://shizune.co/investors/profile/andre-retterath |
| Annette Schiering | Financial Analyst | https://shizune.co/investors/profile/annette-schiering |
| Catrin Schmidt | Team Assistant | https://shizune.co/investors/profile/catrin-schmidt |
| Cem Sertoglu | Co-Founder and Managing Partner | https://shizune.co/investors/profile/m-cem-sertoglu |
| Christian Nagel | Managing Partner | https://shizune.co/investors/profile/dr-christian-nagel |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [PMV](https://shizune.co/investors/profile/pmv-eu) — VC Fund
- [Limburgse Reconversie Maatschappij](https://shizune.co/investors/profile/limburgse-reconversie-maatschappij) — VC Fund
- [Qbic Fund](https://shizune.co/investors/profile/qbic-fund) — VC Fund

## Featured in investor lists
- [Life Science Angel Investors in Europe](https://shizune.co/investors/life-science-angel-investors-europe)
- [Life Science Angel Investors in Belgium](https://shizune.co/investors/life-science-angel-investors-belgium)
- [Health Care Angel Investors in Belgium](https://shizune.co/investors/health-care-angel-investors-belgium)
- [All Angel Investors in Belgium](https://shizune.co/investors/angel-investors-belgium)
- [Life Science Investors in Belgium](https://shizune.co/investors/life-science-investors-belgium)
- [Medical Angel Investors in Belgium](https://shizune.co/investors/medical-angel-investors-belgium)

## FAQ

### What does Evren Ucok invest in?

Evren Ucok invests primarily in Medical, Health Care and Life Science startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in Turkey. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Evren Ucok last invest?

The most recent investment recorded for Evren Ucok closed in Nov 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co